CRANBURY, N.J.--(BUSINESS WIRE)--NeurologyLive®, a multimedia platform dedicated to providing health care professionals who treat neurological diseases with direct access to expert-driven, practice-changing news and insights in neurology, presents its most recent “Peer Exchange” panel discussion in partnership with the Consortium of Multiple Sclerosis Centers (CMSC), “Updates to the MRI Protocol and Clinical Guidelines for MS: CMSC Working Group.” The video series welcomes several experts in the field of neuroscience and radiology who discuss changes to the magnetic resonance imaging (MRI) protocol and clinical guidelines for multiple sclerosis (MS) and strategies for implementation.
“The CMSC is proud to be an ongoing resource for all those affected by multiple sclerosis: the healthcare team and the patients and families who receive expert care, state-of-the-art education, and access to cutting-edge research,” said June Halper, M.S.N., APN-C, MSCN, FAAN, chief executive officer of the CMSC.
This panel features five distinguished experts:
- June Halper, M.S.N., APN-C, MSCN, FAAN, chief executive officer of CMSC, who serves as moderator.
- Frederik Barkhof, M.D., Ph.D., professor of neuroradiology, department of radiology and nuclear medicine, Vrije Universiteit Medical Center Amsterdam.
- David Li, M.D., FRCPC, professor emeritus of radiology, emeritus director UBC MS/MRI Research Group, University of British Columbia.
- Scott D. Newsome, D.O., director, neuroscience consultation and infusion center, associate professor of neurology, Johns Hopkins Medicine.
- Anthony Traboulsee, M.D., FRCPC, professor and research chair, MS Society of Canada at University of British Columbia; medical director of the MS/NMO Clinic, director of the MS/MRI Research Group, director of the MS Clinical Trials Research Group, University of British Columbia Hospital.
“It’s important that the neurology community be aware of changes to imaging and treatment protocols for MS,” said Mike Hennessy Jr., president and CEO of MJH Life Sciences™, the parent company of NeurologyLive®. “NeurologyLive® is proud to partner with the CMSC to help disseminate this important information to our audience of healthcare professionals.”
This “Peer Exchange” series begins with segments on the proposed changes to the MRI protocol and clinical guidelines. The experts will then discuss experiences with implementation and the importance of collaboration across clinical, payor, and patient groups before talking about CMSC’s action plan.
Those attending the 2020 ACTRIMS Forum, February 27-29, 2020 in West Palm Beach, Florida can visit Booth #115 to learn more about the “Peer Exchange” and receive a complimentary copy of the NeurologyLive® February 2020 journal, featuring an editorial by Drs. Traboulsee and Li.
For more information and to view the video series, click here.
A multimedia platform for health care professionals treating neurological diseases, NeurologyLive® delivers direct access to practice-changing news and expert insights directly from top medical conferences and researchers to improve the lives of patients with neurological diseases such as dementia and Alzheimer disease, epilepsy, headache and migraine, movement disorders, multiple sclerosis, neuromuscular diseases, sleep disorders and stroke. The NeurologyLive® platform offers an in-depth look at the hundreds of new treatments in development with ever-expanding mechanisms of action, all during an unprecedented time of growing demand for neurology expertise. The NeurologyLive® platform also connects visitors with the most up-to-date clinical trial results, Food and Drug Administration approvals, practice-changing research and expert insights. NeurologyLive® is a brand of MJH Life Sciences™, the largest privately held, independent, full-service medical media company in North America, dedicated to delivering trusted health care news across multiple channels.